secwatch.observer — SEC 8-K summary
======================================

Issuer:     MapLight Therapeutics, Inc. (MPLT)
CIK:        0001770069
Form:       8-K
Filed at:   2026-06-24T11:12:11+00:00
Accession:  0001193125-26-280243
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

MapLight Therapeutics elects three directors, ratifies RSM US LLP as auditor
----------------------------------------------------------------------------

- Martin Babler, Troy Cox, George Pavlov elected as directors with 89.8%, 99.9%, 97.8% of votes cast.
- Ratification of RSM US LLP as independent auditor approved with 99.9% of votes (36,859,217 for, 22,332 against).
- Turnout: 36,883,750 shares (86.56% of outstanding) present or represented at June 23, 2026 annual meeting.
- Broker non-votes on director election: 1,883,819 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770069/000119312526280243/0001193125-26-280243-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770069/000119312526280243/d119921d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-280243

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer